PXD053403
PXD053403 is an original dataset announced via ProteomeXchange.
Dataset Summary
| Title | GPX1 expression promotes stemness and aggressiveness in sarcomas |
| Description | The sarcomagenic process initiates upon the tumoral transformation of mesenchymal stromal/stem cell (MSCs) or MSC-derived cell types. Experimental evidence also supports that sarcoma evolution is in part driven by the emergence of subpopulations of cancer stem cells (CSCs) after the accumulation of further epigenetic and/or genetic alterations. These CSCs are strongly associated with the evolution of tumors towards more aggressive behaviors. Therefore, the characterization of these subpopulations will contribute to develop more effective therapies against these tumors. With this aim, we used tandem mass spectrometry to the compare the proteome of adherent and CSC-enriched tumorsphere cultures in a tumor progression model of myxoid liposarcoma composed by three cell lines showing increasing aggressiveness after being serially transplanted in mice. In this analysis we found that the expression of the antioxidant enzyme GPX1 increased constantly during the CSC-enrichment process in all the cell lines of the model. Depletion of GPX1 resulted in decreased proliferation, tumorsphere-forming potential and migration capability in vitro and dramatically reduced tumor-formation ability in vivo. Conversely, GPX1 overexpression resulted in increased in vivo tumorigenicity. In agreement with this findings, GPX1 expression in sarcoma patients was associated to advanced tumor stages, more aggressive phenotypes, and a worse prognosis. A proteomic analysis showed that these functional effects were associated with a downregulation of interferon-mediated response, the IL6/JAK/STAT3 axis and the NFκB-mediated signaling in GPX1-silenced cells. Overall, these results suggest that this factor may be a functional marker of aggressive CSCs subpopulations in sarcoma with prognostic and therapeutic implications. |
| HostingRepository | PRIDE |
| AnnounceDate | 2025-10-20 |
| AnnouncementXML | Submission_2025-10-19_19:07:16.940.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Marybeth Creskey |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606; |
| ModificationList | No PTMs are included in the dataset |
| Instrument | Orbitrap Fusion |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
|---|---|---|---|
| 0 | 2024-06-25 11:15:05 | ID requested | |
| ⏵ 1 | 2025-10-19 19:07:18 | announced |
Publication List
| 10.7150/ijbs.105217; |
| Huergo C, Torn, í, n J, Estupi, ñ, á, n O, D, í, ez P, Gallego B, Gao J, Creskey M, Muradia G, Gonz, á, lez MV, Murillo D, Rey V, Mart, í, nez-Cruzado L, Men, é, ndez ST, Rodr, í, guez-Santamar, í, a M, Blanco V, Quir, ó, s I, S, á, inz RM, Rosu-Myles M, Lavoie JR, Rodr, í, guez R, GPX1 expression promotes stemness and aggressiveness in myxoid liposarcomas. Int J Biol Sci, 21(13):5609-5627(2025) [pubmed] |
Keyword List
| submitter keyword: myxoid liposarcoma, proteomics,GPX1, cancer stem cells, sarcoma, oxidative stress |
Contact List
| Jessie Lavoie | |
|---|---|
| contact affiliation | Health Canada |
| contact email | Jessie.Lavoie@hc-sc.gc.ca |
| lab head | |
| Marybeth Creskey | |
| contact affiliation | Health Canada |
| contact email | marybeth.creskey@hc-sc.gc.ca |
| dataset submitter | |
Full Dataset Link List
| Dataset FTP location NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/10/PXD053403 |
| PRIDE project URI |
Repository Record List
[ + ]




